Demographic and clinical comorbidities associated with the severity of infection suggest that possible variants known to influence the renin–angiotensin–aldosterone (RAAS) pathway (those that influence ACE2) may contribute to the heterogenous infection response to COVID-19. Here, ACE2 is linked to COVID-19.